CSIMarket Company Name, Ticker, Customers, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Cash Flow Y/Y Annual
Pfizer Inc  (PFE)
Other Ticker:  
 
 

PFE's Net Cash Flow Growth by Quarter and Year

Pfizer Inc's Net Cash Flow results by quarter and year




PFE Net Cash Flow (in millions $) FY 2022 FY 2021 FY 2020 FY 2019
IV Quarter January - -869.00 805.00 198.00
III Quarter October - -487.00 -384.00 -218.00
II Quarter July 475.00 -688.00 608.00 -351.00
I Quarter April 1,754.00 529.00 -15.00 846.00
FY   2,229.00 -1,515.00 1,014.00 475.00



PFE Net Cash Flow second quarter 2022 Y/Y Growth Comment
Pfizer Inc in the second quarter 2022 achieved Net Cash Flow of $ 475.00 millions compare to net cash outflow recorded in same quarter a year ago.

Looking into second quarter 2022 results within Major Pharmaceutical Preparations industry 47 other companies have achieved higher Net Cash Flow growth. While Pfizer Inc' s Net Cash Flow no change of % ranks overall at the positon no. 665 in the second quarter 2022.


PFE Net Cash Flow ( Y/Y Growth %) 2022
 2021 2020 2019
IV Quarter January - - 306.57 % 58.4 %
III Quarter October - - - -
II Quarter July - - - -
I Quarter April 231.57 % - - -
FY   - - 113.47 % 280 %

Financial Statements
Pfizer Inc's second quarter 2022 Net Cash Flow $ 475.00 millions PFE's Income Statement
Pfizer Inc's second quarter 2021 Net Cash Flow $ -688.00 millions Quarterly PFE's Income Statement
New: More PFE's historic Net Cash Flow Growth >>


PFE Net Cash Flow (Quarter on Quarter Growth %)

 2022
 2021 2020 2019
IV Quarter January - - - -
III Quarter October - - - -
II Quarter July -72.92 % - - -
I Quarter April - -34.29 % - 576.8 %
FY (Year on Year)   - - 113.47 % 280 %


Go to PFE Cash flow Statement >> Back to PFE Growth rate Comparisons >>


Net Cash Flow second quarter 2022 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #48
Healthcare Sector #99
Overall #665

Net Cash Flow Y/Y Growth Statistics
High Average Low
1631.15 % 236.31 % -100 %
(Sep. 30, 2009)   (Dec 31 2011)
Net Cash Flow second quarter 2022 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #48
Healthcare Sector #99
Overall #665
Net Cash Flow Y/Y Growth Statistics
High Average Low
1631.15 % 236.31 % -100 %
(Sep. 30, 2009)   (Dec 31 2011)

Net Cash Flow by Quarter for the Fiscal Years 2019, 2020, 2021, 2022

Pfizer Inc's Q/Q Net Cash Flow Growth


Net Cash Flow Q/Q Growth Statistics
High Average Low
1631.15 % 236.31 % -100 %
(Sep. 30, 2009)  


PFE's II. Quarter Q/Q Net Cash Flow Comment
In the II. Quarter 2022 Pfizer Inc disclosed fall in Net Cash Flow sequentially by -72.92% to $ 475.00 millions, from $ 1,754.00 millions declared in the previous quarter.

Within Major Pharmaceutical Preparations industry 47 other companies have achieved higher Net Cash Flow quarter on quarter growth. While Pfizer Inc's Net Cash Flow growth quarter on quarter, overall rank is 665.


Net Cash Flow Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #48
Healthcare Sector #99
Overall #665
Net Cash Flow Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #48
Healthcare Sector #99
Overall #665
Net Cash Flow Q/Q Growth Statistics
High Average Low
1631.15 % 236.31 % -100 %
(Sep. 30, 2009)  


PFE's II. Quarter Q/Q Net Cash Flow Comment
In the II. Quarter 2022 Pfizer Inc reported fall in Net Cash Flow from the first quarter by -72.92% to $ 475.00 millions, from $ 1,754.00 millions released a quarter before.

Within Major Pharmaceutical Preparations industry 47 other companies have achieved higher Net Cash Flow quarter on quarter growth. While Pfizer Inc's Net Cash Flow growth quarter on quarter, overall rank is 665.


Pfizer Inc's 12 Months Net Cash Flow Growth Year on Year


Net Cash Flow TTM Growth

12 Months Ending
(Jul 02 2023)		 12 Months Ending
(Apr 02 2023)		 12 Months Ending
(Dec 31 2022)		 12 Months Ending
(Oct 02 2022)		 12 Months Ending
(Jul 03 2022)
Cumulative Net Cash Flow 12 Months Ending $ 873.00 $ -290.00 $ -1,515.00 $ -696.00 $ -593.00
Y / Y Net Cash Flow Growth (TTM) - - - - -
Year on Year Net Cash Flow Growth Overall Ranking # # # # #
Seqeuential Net Cash Flow Change (TTM) - - - - -
Seq. Net Cash Flow Growth (TTM) Overall Ranking # # # # #

New: More PFE's historic Net Cash Flow Growth >>



Cumulative Net Cash Flow growth Comment
In the Jul 02 2023 period, Pfizer Inc had cumulative twelve months Net Cash Flow of $ 873 millions compare to net cash outflow of $ -593 millions a year ago.

Pfizer Inc achieved highest trailing twelve month year on year Net Cash Flow growth. While overall Net Cash Flow growth ranking, remained unchanged compare to the previous quarter at no. .

Net Cash Flow TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

Net Cash Flow TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Net Cash Flow TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Net Cash Flow TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative Net Cash Flow growth Comment
In the Jul 02 2023 period, Pfizer Inc had cumulative twelve months Net Cash Flow of $ 873 millions compare to net cash outflow of $ -593 millions a year ago.

Pfizer Inc achieved highest trailing twelve month year on year Net Cash Flow growth. While overall Net Cash Flow growth ranking, remained unchanged compare to the previous quarter at no. .

Net Cash Flow TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 


Net Cash Flow TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Net Cash Flow TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Net Cash Flow TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #




Other Net Cash Flow Growth
Major Pharmaceutical Preparations Industry Net Cash Flow Growth Trends and Statistics
Healthcare Sector Net Cash Flow Growth Statistics
Net Cash Flow Growth Trends for overall market
PFE's Net Cash Flow Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Net Cash Flow Growth
Lowest Ranking Net Cash Flow Growth
Net Cash Flow Growth for PFE's Competitors
Net Cash Flow Growth for Pfizer Inc's Suppliers
Net Cash Flow Growth for PFE's Customers

You may also want to know
PFE's Annual Growth Rates PFE's Profitability Ratios PFE's Asset Turnover Ratio PFE's Dividend Growth
PFE's Roe PFE's Valuation Ratios PFE's Financial Strength Ratios PFE's Dividend Payout Ratio
PFE's Roa PFE's Inventory Turnover Ratio PFE's Growth Rates PFE's Dividend Comparisons



Companies with similar Net Cash Flow fall for the quarter ending Jul 02 2023 within Healthcare SectorY/Y Change %Net Cash Flow for the quarter ending Jul 02 2023
Kewaunee Scientific Corporation-47.04%$ -47.042 millions


Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2023 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com